Objective:

To investigate the relationship between genetic risk and the severity of inflammatory bowel disease (IBD) in patients.

Key Findings:

• Higher genetic risk scores correlated with more severe disease manifestations.
• Patients with higher scores had elevated inflammatory markers and lower hemoglobin levels.
• Increased likelihood of hospitalization, surgery, and intensive treatments in high-risk patients.

Interpretation:

Genetics may play a significant role in determining both the likelihood of developing IBD and the severity of the disease, particularly in ulcerative colitis.

Limitations:

• Genetic risk scores are not yet routinely used in clinical practice.
• The study may not account for all environmental factors influencing disease severity.

Conclusion:

Genetic testing could enhance the prediction of IBD severity, allowing for tailored monitoring and treatment strategies to improve patient outcomes.